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Abstract We report the first case of primary infective
spondylodiscitis due to Lactococcus garvieae, confirmed
by 16S rRNA gene sequencing, in the absence of con-
comitant endocarditis in a patient with long-standing gas-
tritis on famotidine. He responded to a 6-week course of
ampicillin. The gastrointestinal tract is probably the source
of infection.
Introduction
Lactococci are Gram-positive, catalase-negative, faculta-
tive anaerobic cocci in short chains or pairs traditionally
considered to be of low virulence to human beings [1].
Among the eight species and subspecies, Lactococcus
garvieae is responsible for the majority of reported cases of
opportunistic human infections in the literature. Similar to
L. lactis [2], the most well-recognized clinical syndrome of
human L. garvieae infections is infective endocarditis
involving either native or prosthetic valves [3–8]. Other
reported entities included liver abscess [9], peritonitis [7],
diverticulitis [7], and infective spondylodiscitis in associ-
ation with endocarditis [10]. Here, we describe a rare case
of primary infective spondylodiscitis caused by L. garvieae
in the absence of endocarditis in an immunocompetent
patient who was successfully treated with antibiotics alone.
After a thorough review of all of the sporadic reports in the
literature, we conclude that the organism likely causes
opportunistic infections in body systems with local defects
by entering the bloodstream from diseased sites in the
gastrointestinal tract after the ingestion of contaminated
food.
Case report
A 70-year-old Chinese man with long-standing gastritis on
histamine-2 receptor antagonist (famotidine 20 mg twice
daily) was admitted for fever and low back pain for
1 week. On admission, he had a temperature of 38.8C and
localized tenderness at the mid-lumbar spine. Blood tests
showed a total white cell count of 8.67 9 109 l-1 (normal,
4.40–10.10 9 109 l-1) with 79.4% neutrophils (normal,
44.0–72.0%) and a neutrophil count of 6.89 9 109 l-1
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(normal, 2.2–6.7 9 109 l-1), raised C-reactive protein
(CRP) and erythrocyte sedimentation rate (ESR) levels of
5.2 mg dl-1 (normal, \0.76 mg dl-1) and 58 mm/h (nor-
mal, \20 mm h-1), respectively, and normal liver and
renal function tests. A roentgenogram of the lumbar spine
showed degenerative changes, including reduced lumbar
lordosis and marginal osteophytes. Magnetic resonance
imaging of the lumbar spine revealed abnormal contrast
enhancement in the posterior aspect of the L3–4 disc and
end-plate with surrounding soft tissue and epidural
enhancement (Fig. 1). Culture of the percutaneous bone
biopsy of L3–4 yielded tiny non-hemolytic colonies of
Gram-positive cocci in short chains on 5% sheep blood
agar after 24 h of incubation in 5% CO2 at 37C. The
bacterium was grouped as Lancefield group D, catalase-
negative, bile esculin-positive, pyrrolidonyl arylamidase-
positive, arginine-positive, vancomycin-susceptible, and
did not grow in 6.5% NaCl. Although the Vitek (bio-
Me´rieux, Durham, NC, USA) system identified it as
Enterococcus faecium with a 99% confidence level, the
absence of growth in 6.5% NaCl prompted the use of
alternative identification methods. The API Rapid ID 32
Strep (bioMe´rieux, Marcy l’Etoile, France) and the BD
PhoenixTM automated microbiology (Becton–Dickinson
Diagnostics, Sparks, MD, USA) systems identified it as
L. garvieae with 67.7 and 99% confidence levels,
respectively.
16S rRNA gene sequencing of the Gram-positive coccus
was performed according to our previous publications on
the identification of other Gram-positive cocci [11, 12],
using LPW8427 50-GCGAACGGGTGAGTAACG-30 and
LPW8428 50-GACTTCACCCCAATCATC-30 (Sigma-
Proligo, Singapore) as the polymerase chain reaction
(PCR) and sequencing primers. The sequences of the PCR
products were compared with the sequences of closely
related species in GenBank by multiple sequence align-
ment using ClustalX 1.83 [13]. Phylogenetic relationships
were determined using the neighbor-joining method. The
results showed that there was no base difference between
the 16S rRNA gene sequence of the Gram-positive coccus
and that of L. garvieae (GenBank accession no.
FJ915634.1), indicating unambiguously that the Gram-
positive coccus was a strain of L. garvieae (Fig. 2).
Based on the Clinical and Laboratory Standards Insti-
tute’s (CLSI) recommendations on viridan streptococci, the
organism was susceptible to ampicillin, vancomycin, cef-
triaxone, intermediately resistant to penicillin with a min-
imum inhibition concentration of 1.0 lg ml-1, and
resistant to clindamycin [14].
In view of previous reports on infective endocarditis
associated with L. garvieae and a previous report of
Fig. 1 T1-weighted magnetic resonance imaging of the lumbar spine
showing abnormal contrast enhancement in the posterior aspect of the
L3–4 disc and end-plate with surrounding soft tissue and epidural
enhancement (arrow)
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Fig. 2 Phylogenetic tree showing the relationships of the patient’s
isolate to other closely related Lactococcus species. The tree was
inferred from 16S rRNA data by the neighbor-joining method using
Kimura’s two-parameter correction and was rooted using the 16S
rRNA gene sequence of Streptococcus gallinaceus (NR_025453.1).
Bootstrap values were calculated from 1,000 trees. The scale bar
indicates the estimated number of substitutions per 100 bases. Names
and accession numbers are given as cited in the GenBank database
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concomitant infective spondylitis and infective endocardi-
tis [10], transthoracic echocardiogram was performed,
which showed normal heart valves without any vegetation.
Three sets of blood cultures taken before the use of anti-
biotics were negative and no clinically apparent immuno-
logic or vasculitic phenomenon was observed. He was,
thus, treated as a case of acute osteomyelitis with a 6-week
course of intravenous ampicillin 2 g q6h and responded
well clinically. The neutrophil count, CRP, and ESR levels
normalized after 18 days of treatment. He was discharged
64 days after admission and remained well at follow-up
3 months afterwards.
Discussion
L. garvieae was separated from the Streptococcus genus in
1985 [15]. It was first isolated from bovines with mastitis
[1] and, subsequently, from fish and human specimens
[16]. It causes mastitis in ruminants, and lactococcosis, a
septicemic infection characterized by hemorrhagic enteri-
tis; bilateral exophthalmos; darkening of the skin; and
congestion of the intestine, liver, kidney, spleen, and brain,
in fish [16, 17]. In the recent years, it has gained recogni-
tion as an emerging zoonotic pathogen, since an increasing
number of cases of human infections due to L. garvieae
have been encountered. Furutan et al. [18] first described
the possible association between the organism and pros-
thetic valve endocarditis in 1991, although no clinical
details were mentioned. Subsequently, including our
patient, a total of 12 cases with clinical details have been
reported in the English literature (Table 1). Six cases pre-
sented with infective endocarditis (five infecting native
valves and one prosthetic valve) [3–8], one had liver
abscess [9], one had septicemia with multiorgan failure [7],
one had diverticulitis [7], one had secondary peritonitis [7],
and one had infective spondylodiscitis associated with
probable endocarditis [10]. Ten out of the 12 cases (83%)
had bacteremia. The present case is the first in describing
L. garvieae infective spondylodiscitis in the absence of
endocarditis and detectable bacteremia.
Although their clinical presentations vary, a number of
similarities among these patients who developed infection
due to this relatively avirulent organism can be observed by
thorough analysis of the reported cases (Table 1). Con-
cerning the probable pathogenesis, most of them started off
with an anatomically or physiologically disturbed gastro-
intestinal tract (9/12, 75%), in the form of past surgery,
active pathology, or the use of gastric acid suppressive
therapy. As in our patient, who had regular visits to fish
markets and intake of sashimi, the likely route of infection
was often through the ingestion of contaminated fish [7].
Half of the cases had documented exposure to raw fish
(6/12, 50%), while the history was not mentioned in some
of the other cases. The bacterium, after being acquired,
then caused infection in the body systems with local pre-
disposing factors (9/12, 75%), including valvular abnor-
malities in endocarditis, biliary tract tumor with prosthetic
stenting in liver abscess, diverticular disease in septicemic
diverticulitis, ruptured bowel in peritonitis, and degenera-
tive spine in infective spondylodiscitis. These observations
were well illustrated in our patient: chronic gastritis, long-
term acid-suppressive therapy, regular intake of raw fish,
and underlying degenerative spine. Thus, instead of
developing infective spondylodiscitis due to other more
common organisms [19, 20], our patient developed the
disease secondary to L. garvieae.
Human infections caused by L. garvieae are associated
with significant morbidity and mortality. For the nine
patients who survived, most received prolonged courses
(median 6 weeks) of antibiotics, mainly consisting of high-
dose b-lactams with or without aminoglycosides, and sur-
gical interventions were also performed in three patients
(Table 1). Of note, while clindamycin is often being used
in cases of infective spondylodiscitis caused by other
Gram-positive organisms such as staphylococci and strep-
tococci, it would be ineffective against L. garvieae, as the
organism is always resistant. Alternatively, oxacillin could
be considered, as the bacterium is usually susceptible [21].
However, even despite appropriate antibiotic use and
maximal supportive treatment, three patients (3/12, 25%)
died as a result of cerebral hemorrhage complicating mitral
valve replacement for infective endocarditis, hemobilia in
cholangiocarcinoma with liver abscess, and multiorgan
failure in concomitant Klebsiella pneumoniae and L. gar-
vieae bacteremia (Table 1). This highlights the fact that,
while three-quarters of cases of L. garvieae infections were
treatable, a significant proportion could be fatal if serious
complications, incurable comorbidities, or coexisting
infections are present.
In summary, human infections due to L. garvieae are
rare. The most common manifestation is infective endo-
carditis. Our case is the first case of primary infective
spondylodiscitis in the absence of endocarditis. A thorough
review of the literature suggests that the organism is
probably acquired from the ingestion of contaminated food,
especially raw fish, which then enters the bloodstream via
anatomically or physiologically altered gastrointestinal
tract, and, from there, spreads to infect distant sites with
local predisposing pathologies. At-risk individuals, partic-
ularly those who have an anatomically or physiologically
altered gastrointestinal tract, and coexisting local predis-
posing defects, especially valvular heart disease, are,
therefore, discouraged from eating undercooked food, as
this emerging zoonotic bacterium with supposedly low
virulence is capable of causing serious infections with
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potential morbidities and mortalities. Accurate identifica-
tion of the bacterium is essential and can be achieved by
16S rRNA gene sequencing.
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